1. 516 THE CHARACTERIZATION OF DYSPLASIA IN BARRETT'S ESOPHAGUS—A PROSPECTIVE NATIONWIDE REGISTRY FROM THE RIBBON NETWORK. (14th September 2020) Authors: O Byrne, L; O' Brien, M; Muldoon, C; Ryan, C; Buckley, M; Murphy, T; Reynolds, R; Patchett, S; Kay, E; Azam, H; Robb, W; Arumugasamy, M; Mc Mathuna, P; Leyden, J; Gargan, S; Doherty, G; Sheahan, K; Collins, C; O Sullivan, J; Donohoe, C Journal: Diseases of the esophagus Issue: Volume 33(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5 Outcomes following ANTI-TNF discontinuation and the risk of relapse in inflammatory bowel disease; a single centre experience. (5th April 2017) Authors: Coffey, L; Mullen, A; Leyden, J; MacMathuna, P Journal: Gut Issue: Volume 66(2017)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A REVIEW OF GASTRIC ULCER FOLLOW-UP PRACTICES IN A TERTIARY CARE GASTROENTEROLOGY SERVICE. (8th June 2013) Authors: McGlacken-Byrne, S; Lahiff, C; MacMathuna, P; Leyden, J Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An unusual finding in a patient with iron deficiency anaemia. Issue 10 (14th September 2005) Authors: Leyden, J; O'Shea, C; Hegarty, S; MacMathuna, P Journal: Gut Issue: Volume 54:Issue 10(2005) Page Start: 1491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P483 Golimumab response in Ulcerative Colitis as early as week 2: What can we take from this?. (30th January 2023) Authors: Kumar, L; O'Morain, N; Sheridan, J; Coe, C; Egan, C; Jones, F; Cullen, G; Doran, P; Leyden, J; Galligan, M; McCarthy, J; O'Toole, A; Kevans, D; Egan, L; Doherty, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P557 Sustained remission in inflammatory bowel disease patients after discontinuing infliximab; the ongoing reluctance to stop biologics. (25th January 2019) Authors: Ryan, T; Coffey, L; Mullen, A; Leyden, J; MacMathuna, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. STREAMLINING INPATIENT COLONOSCOPY IN A TERTIARY CARE GI SERVICE. (8th June 2013) Authors: Murphy, K; Lahiff, C; MacMathuna, P; Leyden, J Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗